ZyVersa Therapeutics Inc. logo

ZyVersa Therapeutics Inc. jobs and careers

United States

About ZyVersa Therapeutics Inc.

ZyVersa (Nasdaq: ZVSA) is a clinical stage specialty biopharmaceutical company leveraging two licensed proprietary product platforms to develop pharmaceutical products that address unmet medical needs in the areas of renal and inflammatory diseases. Lead renal candidate, Phase 2a-ready VAR 200, mediates removal of excess intracellular lipids in the kidney’s filtration system that contribute to kidney damage leading to end-stage kidney disease. Lead anti-inflammatory drug candidate, inflammasome ASC inhibitor (IC 100), blocks initiation and perpetuation of damaging inflammation that’s pathogenic in a multitude of inflammatory diseases.

Employees
11 to 50
Headquarters
United States

Leadership

The top of ZyVersa Therapeutics Inc.'s org chart, with how many people report into each leader.

SGPhoto of Steve Glover

Steve Glover

Co-Founder, Chairman and Chief Executive Officer

Jobs at ZyVersa Therapeutics Inc.

No open positions right now. Explore more companies on TheJobsMap.